Sources Sought for Small Businesses - IgE Testing
ID: NHANESIgEType: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/70b54a3be20c43ad8b180dcfb602a24f/view
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is conducting market research to identify small businesses capable of performing allergen-specific immunoglobulin E (IgE) testing as part of a future procurement initiative. The selected contractor will be required to analyze IgE levels from approximately 20,000 individuals, focusing on 21 specific allergens, while ensuring compliance with regulatory standards and maintaining participant confidentiality. This testing is crucial for providing national health statistics and insights into allergic diseases, particularly in response to changing environmental factors. Interested small businesses should submit a summary of their capabilities to Michael Gilham at ueh8@cdc.gov by 4 PM Eastern Time on October 21, 2024, as this is not a solicitation for a contract but a request for information.

    Point(s) of Contact
    Michael Gilham
    (301) 458-4598
    ueh8@cdc.gov
    Files
    Title
    Posted
    SOW IgE.pdf
    The NHANES IgE Laboratory Testing contract spanning from 2025 to 2029 seeks a CLIA-certified laboratory to perform testing on immune responses to specific allergens prevalent in the U.S. The contract, issued by the National Center for Health Statistics, mandates the analysis of immunoglobulin E (IgE) levels from approximately 20,000 individuals to provide national health statistics. The primary objectives include measuring 21 allergen-specific IgEs, developing laboratory procedure manuals, and supplying timely test data within 21 days of sample receipt. The contractor will ensure compliance with regulatory standards while maintaining participant confidentiality. Quality assurance measures, including the submission of quarterly reports and the validation of testing methods, will be implemented. Samples will be collected year-round, with specified storage conditions to ensure integrity. This initiative will provide crucial insights into allergic diseases, particularly in the context of changing environmental factors, supporting public health efforts and ongoing surveillance. All data produced will remain the property of the government, and the contractor will be responsible for adhering to confidentiality laws regarding participant information.
    Lifecycle
    Title
    Type
    Sources Sought for Small Businesses - IgE Testing
    Currently viewing
    Sources Sought
    Similar Opportunities
    Serological Assays for the detection and characterization of influenza viruses
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking contractors for the provision of serological assays aimed at detecting and characterizing influenza viruses. This contract encompasses a 12-month base period with four additional 12-month option periods, focusing on testing immunological responses from human samples collected during vaccine effectiveness studies, randomized controlled trials, and outbreak investigations using Hemagglutination Inhibition (HAI) assays. The services are critical for understanding vaccine efficacy and managing influenza outbreaks, with the government supplying necessary standard operating procedures, proficiency panels, and controls to ensure proper assay performance. Interested parties should contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020 for further details, as this opportunity is set aside for small businesses under the SBA guidelines.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for the NIAID Clinical Products Center (CPC) contract, aimed at supporting clinical trials focused on immunologic, infectious, and allergic diseases. The contract will provide essential pharmacy and pharmaceutical oversight for national and international clinical trials, ensuring product integrity, participant safety, and compliance with regulatory standards, while also expanding support for additional NIH-funded trials and emergency public health programs as needed. This initiative is critical for advancing research in various immune-mediated diseases, including asthma, autoimmune disorders, and organ transplant rejection. Interested parties should prepare to submit proposals electronically via the NIAID electronic Contract Proposal Submission (eCPS) website, with the presolicitation notice expected to be published on or around October 18, 2024. For further inquiries, contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov.
    Combined Synopsis/Solicitation for Illumina Maintenance Service
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source firm fixed-price contract for maintenance services of Illumina NovaSeq 6000 and MiSeq sequencing instruments. The procurement aims to ensure the availability of manufacturer-approved repair and maintenance services, which are critical for supporting outbreak studies and public health emergencies, with a performance period from December 7, 2024, to December 6, 2025. This contract is essential for the CDC's Genomic Sequencing Laboratory (GSL) to maintain high-quality operations, particularly during times of increased demand for sequencing services. Interested parties must submit their proposals to James Brown III at xvn8@cdc.gov by 12:00 P.M. EDT on October 21, 2024, with an estimated contract value of $144,910.12.
    A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are soliciting proposals from small businesses for the Small Business Innovation Research (SBIR) program, specifically under Solicitation Number PHS-2025-1. This opportunity aims to stimulate technological innovation and strengthen the role of small businesses in addressing federal research and development needs across various health-related topics, including cancer research, aging, infectious diseases, and mental health. Eligible small businesses are encouraged to submit proposals that demonstrate technical feasibility and commercial potential, with a closing date for submissions set for October 18, 2024. For further inquiries, interested parties may contact Callie Prassinos at Callie.Prassinos@NIH.gov or Julie Rodriguez at ncioasbir@mail.nih.gov.
    ICE COVID-19 Testing Supplies
    Active
    Homeland Security, Department Of
    The Department of Homeland Security, specifically the Immigration and Customs Enforcement (ICE), is seeking suppliers for COVID-19 testing supplies, including rapid molecular and antigen tests, to support its Health Service Corps and Enforcement and Removal Operations. The procurement aims to fulfill the testing needs across 18 ICE facilities, with a monthly requirement of 1,056 rapid molecular tests and 2,700 antigen tests, as detailed in the draft Statement of Work (SOW). This initiative is critical for maintaining health standards within detention facilities, ensuring timely and accurate testing capabilities as part of the government's public health response. Interested vendors should contact Gena Braden at genna.braden@ice.dhs.gov or call 682-218-7283, with responses to the Request for Information due by October 25, 2024.
    RFI and draft PWS - World Trade Center Health Program Third-Party Administrator
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is seeking industry feedback on a draft Performance Work Statement (PWS) for a Third-Party Administrator (TPA) for the World Trade Center (WTC) Health Program. The TPA will be responsible for managing enrollment applications, processing medical claims, maintaining member information, and administering benefits for approximately 135,000 individuals affected by the September 11 attacks. This program is crucial for providing medical monitoring and treatment for WTC-related health conditions, ensuring high-quality healthcare delivery to impacted populations. Interested parties are encouraged to submit their feedback by October 25, 2024, to Contract Specialist Joshua Houston at jhouston@cdc.gov, with a solicitation expected to be released around mid-January 2025.
    RFI for World Trade Center Health Program (WTCHP) Mental Health Evaluation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is seeking qualified vendors to respond to a Request for Information (RFI) aimed at developing a specialized mental health provider network for the World Trade Center Health Program (WTCHP). The primary objective is to address the unique mental health needs of WTCHP members, particularly those affected by 9/11-related conditions, by ensuring timely access to outpatient services and integrating these services with existing care teams while overcoming challenges such as provider shortages and billing complexities. This initiative is crucial for enhancing the quality of care and service delivery for individuals impacted by the events of September 11, 2001. Interested parties are encouraged to submit their responses detailing their experience and proposed solutions by contacting Eugenia J. Corder at xvn9@cdc.gov or by phone at 404-498-4855. This RFI is for information and planning purposes only and does not constitute a solicitation for proposals.
    Nitrile and Vinyl Glove Testing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking proposals for laboratory testing services of disposable nitrile and vinyl examination gloves as part of solicitation 75A50324R00016. The primary objective is to conduct biocompatibility testing and statistical sampling to ensure that the gloves meet the necessary ASTM and ISO safety standards, which are critical for protecting healthcare providers and patients from infection risks. This procurement is vital for maintaining the Strategic National Stockpile (SNS) and ensuring the availability of effective personal protective equipment during emergencies. Proposals are due by October 21, 2024, and interested contractors should contact Lawrence McCoy at Lawrence.Mccoy@hhs.gov for further information.
    RFI - World Trade Center (WTC) Health Program's Medical Coding System Transition
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking insights from qualified organizations regarding the transition of the World Trade Center (WTC) Health Program's medical coding system from ICD-9 to ICD-10 and beyond. The primary objective of this Request for Information (RFI) is to identify effective methods for automating updates to member certification files, ensuring alignment with valid ICD codes to maintain the integrity of the certification process for 9/11 Responders and Survivors. This initiative is crucial for ensuring continued access to necessary healthcare services for individuals affected by the events of September 11, 2001, as established under the James Zadroga 9/11 Health and Compensation Act of 2010. Interested parties are invited to submit a white paper by November 26, 2024, detailing their experience and capabilities related to coding transitions, with inquiries directed to Laurie Presley at xnp0@cdc.gov.
    Waste Removal and Recycling Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified contractors to provide waste removal and recycling services at the National Institute for Occupational Safety and Health (NIOSH) facilities located in Morgantown, West Virginia. The procurement includes weekly domestic waste removal and monthly single stream recycling services, with the contractor responsible for all associated costs, including dumpster rental and transportation. This contract is crucial for maintaining operational efficiency and compliance with environmental standards, and it emphasizes inclusivity by adhering to Section 508 of the Rehabilitation Act. The Request for Quotations (RFQ) is expected to be released at the end of November 2024, with a firm-fixed price contract spanning from February 1, 2025, to January 31, 2030, and interested small businesses should direct inquiries to Joseph Butkus at jbutkus@cdc.gov.